Concepedia

Xinliang Mao

XM

86

Publications

3.9K

Citations

40

H-Index

1994

Active since

Affiliations

Soochow University(Current)

First Affiliated Hospital of Soochow University

Guangzhou Medical University

University of Toronto

Princess Margaret Cancer Centre

Xinliang Mao is an author at Soochow University specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

1994–2024

86

Publications

86

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death

Tabitha E. Wood, Shadi Dalili, Craig D. Simpson et al. · Molecular Cancer Therapeutics · 2008 · 196 citations

The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma

G. Wei Xu, Mohsin Ali, Tabitha E. Wood et al. · Blood · 2010 · 167 citations · Full text

Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo

Rodger E. Tiedemann, Jessica Schmidt, Jonathan J. Keats et al. · Blood · 2008 · 111 citations · Full text

Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen

Kenneth W. Yip, Xinliang Mao, P Au et al. · Clinical Cancer Research · 2006 · 98 citations · Full text

Intrinsic RNA (guanine-7) methyltransferase activity of the vaccinia virus capping enzyme D1 subunit is stimulated by the D12 subunit. Identification of amino acid residues in the D1 protein required for subunit association and methyl group transfer.

Xinliang Mao, Stewart Shuman · Journal of Biological Chemistry · 1994 · 97 citations · Full text

, , +15

Rows per page

1–5 of 86